of a wide range of products which include 5mg tofajak tofacitinib tablets, 11mg tofajak in tofacitinib tablets, ivepred 8mg tablet and acecloheal sp acecloheal paracetamol serratiopeptidase tablet.
Tofajak (Tofacitinib) is a Janus kinase (JAK) inhibitor taken orally that is used to treat several inflammatory conditions. These conditions include moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. The medication works by suppressing an overactive immune system, which helps to reduce inflammation, pain, and stiffness in the joints. Tofajak is typically taken twice daily, and it can be taken with or without food.
Tofajak-IN XR 11 mg Tablet is an extended-release, disease-modifying anti-rheumatic drug (DMARD) containing 11mg Tofacitinib, a Janus kinase (JAK) inhibitor used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It reduces inflammation, pain, and joint damage by suppressing an overactive immune system.
Ivepred 8 mg tablets contain the active ingredient methylprednisolone, which is a corticosteroid medication used to treat a wide range of inflammatory and autoimmune conditions. It works by suppressing the immune system and reducing inflammation throughout the body.
Acecloheal SP is a combination tablet containing Aceclofenac (100mg100 mg100mg), Paracetamol (325mg325 mg325mg), and Serratiopeptidase (10mg10 mg10mg), used for short-term relief of pain, inflammation, and swelling associated with arthritis, muscle injuries, and post-operative recovery.